Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07804979) titled 'Comparison of Efficacy of Minocyclin and Celecoxib as Adjunctive Treatment in Treatment Resistant Cases of Major Depressive Disorder' on Sept. 1.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Participant).
Primary Sponsor: Lahore General Hospital
Condition:
Major Depressive Disorder (MDD)
Treatment-resistant Depression (TRD)
Intervention:
Drug: Minocycline
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: May 12, 2022
Target Sample Size: 78
Countries of Recruitment:
Pakistan
...